NICE to ensure integrated approach to following safety recommendations
- PDF / 170,458 Bytes
- 1 Pages / 595.245 x 841.846 pts (A4) Page_size
- 33 Downloads / 187 Views
1
NICE to ensure integrated approach to following safety recommendations The UK National Institute for Health and Care Excellence (NICE) has agreed to collaborate with regulators and healthcare organisations to ensure an integrated approach to following safety recommendations made in NICE guidance. This follows the publishing of the First Do No Harm report of the Independent Medicines and Medical Devices Safety (IMMDS) Review, which found that following NICE guidance more closely may have avoided harmful adverse events in patients. The review assessed how the healthcare system in England responded to reports from patients about adverse events associated with: a hormonal pregnancy test [Primados] which was withdrawn from the UK market in 1978; the use of sodium valproate during pregnancy; and the use of surgical mesh in the treatment of pelvic organ prolapse and stress urinary incontinence between 2016 and 2017 (NICE updated Interventional Procedures guidance on this issue before the review was announced). The review found that "more should have been done to ensure that healthcare professionals were aware of and following guidelines. In theory, regulators and professional organisations . . . reinforce their use through their professional standards and inspection or accreditation processes". It acknowledged that the NICE guidance was appropriate to known risks and alternatives. The NICE board supported the need for more collaboration with regulators and professional organisations to reinforce the use of NICE guidance through their professional standards and inspection or accreditation processes, and has agreed: "to consider how to facilitate the production of a single and collaboratively produced patient decision aids; to work with NHSX and other system partners to co-create databases and registries which could be used to inform our guideline development; and for an exceptional review to be carried out on its guideline on the management of urinary incontinence and pelvic organ prolapse in women". It also agreed to collaborate with other partners in a coordinated system response to the IMMDS Review overseen by the Department of Health and Social Care. "During the review we worked with partners from across the health and care system to implement improvements and ensure a more integrated approach to patient safety. This work will continue," said Professor Gillian Leng, chief executive at NICE. NICE. NICE board agrees to stimulate action following publication of Independent Medicines and Medical Devices Safety Review report. Internet Document : 23 Sep 2020. Available from: URL: https://www.nice.org.uk/news/article/nice-board-agrees-to-stimulate-action-following-publication-of-independent-medicines-and-medical-devices-safety803504975 review-report
0114-9954/20/1824-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved
Reactions 3 Oct 2020 No. 1824
Data Loading...
